A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone
Article in Targeted Oncology (April 2024)
The most recent citing publications are shown below. View all 149 publications that cite this research output on Dimensions.
Article in Targeted Oncology (April 2024)
Article in Disease Markers (April 2024)
Article in Frontiers in Oncology (April 2024)